CAN FITE BIOPHARMA LTD (CANF)
Can-Fite Secures Japanese Patent Allowance for Namodenosons Anti-Obesity Technology
Can-Fite Secures Japanese Patent Allowance for Namodenosons Anti-Obesity Technology
Jade Biosciences Announces Appointment of Mark Eisner, M.D., M.P.H., to Board of Directors
Axsome Therapeutics Initiates FOCUS-3 Phase 3 Trial of Solriamfetol in Adolescents with Attention Deficit Hyperactivity Disorder (ADHD)
Catalyst Bancorp, Inc. and Lakeside Bancshares, Inc. Announce Shareholder and Regulatory Approvals for Pending Mergers
Highlander Silver Announces Results of Annual General Meeting of Shareholders
Baker Hughes Announces Dates for Second-Quarter Earnings Release and Webcast
Kyivstar and Ukraine’s Securities Regulator Sign Memorandum to Advance Capital Markets Development and Expand Investment Access
Aurora Mobile’s JPush Empowers Yuanda Information’s Caiyuan Gungun App with Millisecond-Level, Precise User Engagement
New Autism Research to be Presented at European Purine Scientific Meeting
Fortrea Names Jason Knoblauch as Chief Financial Officer